All News
Earnings_Preview ACN $179.92

ACN Earnings Oct 1: $3.18 EPS Consensus, Key Levels to Watch

The setup heading into Accenture's October 1 report is mixed-to-cautious: the stock has pulled back nearly 7% from its September peak, analysts have been net-cutting estimates, and the options market is sending a neutral-to-bearish signal โ€” yet the longer-term uptrend remains intact and institutional accumulation has been significant.

ACN price chart with options gamma levels ahead of 2026-10-01 earnings

The Setup: Pulling Back from Recent Highs

Accenture shares are trading at $183.52, down 7.1% from their recent high of $197.63 reached on September 15 โ€” just nine trading days before the print. That retreat has pushed ACN back below its 20-day SMA of $186.22, though it remains comfortably above its 50-day SMA of $173.91. The short-term (5-day) trend is pointing down, with the stock losing 3.56% in that window and trading within a descending channel.

The 20-day trend still leans up (+1.18%), with trendline support sitting at $180.70 โ€” roughly 1.5% below the current price. The 100-day picture shows a moderate uptrend, with the stock positioned above its long-run mean (a bullish structural read), though relative strength versus the broader market is assessed as weak. The range over the past month โ€” from a low of $175.49 on September 10 to the high of $197.63 โ€” illustrates just how volatile ACN has been heading into this quarter.

On the fundamental side, Accenture carries a forward P/E of 12.6x and a PEG ratio of 1.35, which looks reasonable for a large-cap IT services firm of its quality. Return on equity sits at a healthy 24.4%, and the stock yields approximately 3.5% in dividends. The street's mean price target is $191.61, implying just 4.4% upside from current levels โ€” a modest cushion that doesn't leave a lot of room for disappointment.

What the Options Market Says

Options flow for ACN scores 68 out of 100 โ€” one of the stronger individual signals in the overall picture โ€” but the broader flow classification reads as distribution, with the MACD signal turning bearish. RSI sits at a neutral 51.7, suggesting neither overbought nor oversold conditions heading into the print.

The call wall is stacked at the $200 strike (38,158 contracts in open interest), while the put wall sits considerably lower at $150 (40,028 contracts). The wide corridor between these two levels โ€” $150 to $200 โ€” reflects how dealer positioning brackets the stock rather than defining a tight expected move. This is a 28-point range centered on a stock trading at $183, meaning market makers are hedged across a wide band rather than clustered tightly around current price.

On pre-earnings positioning, call open interest is building notably at the $180 strike (+10,782 contracts) and the $200 strike (+5,208 contracts), suggesting some traders are positioning for a hold-or-rally scenario. Put builds are concentrated at $165 (+5,286 contracts) and deep out-of-the-money strikes at $120 and $125 โ€” the latter likely portfolio hedges rather than directional bets. Overall pre-earnings options bias is assessed as neutral.

The options confidence score for ACN comes in at 44/100, classified as neutral-to-bearish with low confidence. Combined with a distribution flow signal and negative analyst revision momentum, this is not a setup where options premium is pricing in a clear directional thesis โ€” which makes naked directional trades ahead of earnings particularly difficult to justify on a risk/reward basis.

Fundamentals & Estimates: Modest Growth, Downward Revisions

The consensus expects Accenture to report fiscal Q4 2026 EPS of $3.18 (range: $3.12โ€“$3.23), up approximately 5% year-over-year from the $3.03 earned in the same quarter last year. Revenue consensus sits at $18.04 billion (range: $17.82Bโ€“$18.17B), representing growth of roughly 2.5% versus the $17.60 billion reported a year ago.

For the full fiscal year 2026, analysts model EPS of $13.87 on revenues of approximately $73.6 billion, implying 7.2% EPS growth and 5.6% revenue growth versus fiscal 2025. Looking ahead to fiscal 2027, estimates call for EPS of $14.67 on revenues of $76.6 billion.

The revision picture, however, is a meaningful concern. Over the past 30 days, analysts have submitted 7 downward EPS revisions against just 1 upward, for a net revision score of -6. That kind of lopsided cutting ahead of a print is a yellow flag โ€” it suggests analysts are getting cautious about near-term execution rather than becoming more confident. The full-year EPS estimate has barely budged: $13.866 today versus $13.872 thirty days ago and $13.856 ninety days ago, pointing to a very tight consensus with little room for positive surprise.

On the ratings side, the street is skewed toward hold: 15 hold ratings, 9 buys, 3 strong buys, and zero sells. That distribution โ€” dominated by holds โ€” reflects a lack of strong conviction in either direction at current valuation.

Key Levels to Watch

Level Price Significance
Call Wall / Resistance $200.00 Heavy call OI (38,158 contracts); dealer supply above this level
Recent High $197.63 September 15 peak; must reclaim to signal bullish earnings reaction
100-Day Resistance $196.35 Long-run trendline cap; breakout above confirms renewed uptrend
Street Mean Target $191.61 Analyst consensus; modest upside from current price
20-Day SMA $186.22 First overhead resistance to reclaim post-earnings
Current Price $183.52 Trading near lower half of recent range
20-Day Trendline Support $180.70 Key near-term floor; a close below raises downside risk
Put Wall $150.00 Heavy put OI (40,028 contracts); dealer support floor

If ACN beats estimates and management delivers a constructive outlook on AI-driven consulting demand, the first target is a reclaim of the 20-day SMA at $186.22, with a clean beat potentially driving a test of the September high near $197.63. Holding above $180.70 post-earnings is the minimum requirement to keep the 20-day uptrend intact.

If Accenture misses on revenue or delivers cautious forward guidance โ€” a plausible scenario given 7 of 8 recent analyst revisions have been cuts โ€” the 20-day support at $180.70 becomes the first line of defense. A breakdown below that level opens a path toward the September low of $175.49. Given the stock is already down 7% from its recent peak, the market may have already begun pricing in modest disappointment โ€” but a guidance cut could steepen the decline further.

Bottom Line

Accenture enters its October 1 earnings report at $183.52 with a mixed technical and fundamental setup. The consensus EPS of $3.18 (+5% YoY) is achievable, but the bar for a positive stock reaction is higher than the headline number alone โ€” investors will be focused on management's commentary around AI consulting pipelines, large deal bookings, and full-year 2027 guidance. With the stock 7% off its recent peak, negative revision momentum, and an investment score of just 39.8/100, the path of least resistance favors caution ahead of the print. Defined-risk structures โ€” rather than outright directional bets โ€” are better suited to navigating the wide $150โ€“$200 dealer positioning corridor into this report. Watch the $180.70 support and the $191.61 mean analyst target as the two most important post-earnings signposts.

Want this analysis for any stock, on demand? Ask Alpha Assistant โ€” AI analysis backed by live scores, options flow, gamma walls and supply-chain data.

This article was generated by Tradestie Alpha Assistant using live market data (investment scores, options positioning, trendlines, and fundamentals) and reviewed before publication. It is for informational purposes only and is not financial advice. Do your own research before making investment decisions.